Evidence map›Paper›PMID 41153405›Full record

ReviewGenes2025

Dirty Ends: Formation, Repair, and Biological Relevance of Non-Canonical DNA Terminal Structures.

Seanmory Sothy, Linlin Zhao

Abstract readReview
In one paragraph

Review in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Seanmory SothyDepartment of Chemistry, University of California, Riverside, Riverside, CA 92521-0403, USA.
Linlin ZhaoDepartment of Chemistry, University of California, Riverside, Riverside, CA 92521-0403, USA.ORCID 0000-0002-8821-4198

Funding

Chemical and Molecular Mechanisms of Mitochondrial DNA DegradationR35GM128854 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Linlin Zhao · 2018 to 2026
$3.1M
NIGMS NIH HHS R35 GM128854NIH HHS 1R35GM128854-07
6 · The paper itself

Abstract

Human DNA is continuously exposed to endogenous and exogenous agents that generate over 100,000 lesions per cell each day. In addition to damage to nucleobases, deoxyribose, and phosphate groups, a particularly harmful class of lesions involves non-canonical DNA termini-structures deviating from the canonical 3'-hydroxyl and 5'-phosphate ends. These aberrant DNA ends can obstruct essential DNA transactions and, if left unrepaired, contribute to cytotoxicity and mutagenesis. Their biological significance is further highlighted by the severe pathologies linked to deficiencies in DNA end-processing enzymes, including inflammation, cancer predisposition syndromes, neurodegeneration, and aging. This review highlights recent advances in our understanding of the formation, prevalence, and repair mechanisms of several key non-canonical DNA end structures, including 3'-phosphate, 3'-phosphoglycolate, 3'-α,β-unsaturated aldehyde and its glutathione derivative, 5'-deoxyribose-5-phosphate, 2'-deoxyribonucleoside-5'-aldehyde, and 5'-adenosine monophosphate. These non-canonical DNA terminal structures arise from various sources, such as radical-induced oxidation of the 2-deoxyribose moiety and DNA repair pathways. While this review does not cover the full spectrum of non-canonical termini, the selected structures are emphasized based on quantitative data supporting their biological relevance. The review also discusses their broader implications in mitochondrial DNA maintenance and inflammatory signaling and highlights key knowledge gaps that warrant further investigation.

Indexed as

DNADNA DamageDNA RepairAnimalsHumansDNA2-deoxyribose oxidationbase excision repairDNA damageDNA repair intermediatesimmune signalinginflammationmitochondrial DNAnucleic acid modifications

Identifiers

PMID41153405
PMCPMC12564780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.